addbio top3

News Feed

Update on AddBIO's clinical study

The study entitled ‘A randomized, multicentre, double blind, parallel study to evaluate the performance and safety of the Zolidd One ExHex dental implant compared to uncoated One ExHex dental implant in subjects with partial edentulism’ started during the fall at our three contracted clinical sites. As of December, 50% of the total 62 patients has been enrolled in the study. The recruitment of patients will continue during January and February 2018. We are looking forward to an exciting year of 2018!